AAAAAA
Results:
1-16
|
Results: 16
Authors:
Noldus, J
Michl, U
Graefen, M
Haese, A
Hammerer, P
Fernandez, S
Huland, H
Citation: J. Noldus et al., Nerve-sparing radical retropublic prostatectomy. Outcome analysis based onpatient questionnaires, UROLOGE A, 40(2), 2001, pp. 102
Authors:
Prange, W
Erbersdobler, A
Hammerer, P
Graefen, M
Hautmann, SH
Hautmann, RE
Huland, H
Henke, RP
Citation: W. Prange et al., High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens, EUR UROL, 39, 2001, pp. 30-31
Authors:
Lein, M
Jung, K
Hammerer, P
Graefen, M
Semjonow, A
Stieber, P
Ossendorf, M
Luboldt, HJ
Brux, B
Stephan, C
Schnorr, D
Loening, SA
Citation: M. Lein et al., A Multicenter Clinical Trial on the use of alpha(1)-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis, PROSTATE, 47(2), 2001, pp. 77-84
Authors:
Prange, W
Erbersdobler, A
Hammerer, P
Graefen, M
Hautmann, SH
Hautmann, RE
Huland, H
Henke, RP
Citation: W. Prange et al., Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimens, UROLOGY, 57(3), 2001, pp. 486-490
Authors:
Hammerer, P
Semjonow, A
Citation: P. Hammerer et A. Semjonow, 10 years of PSA - chemoprevention, UROLOGE A, 39(4), 2000, pp. 302-303
Authors:
Hammerer, P
Graefen, M
Steuber, T
Huland, H
Citation: P. Hammerer et al., Chemoprevention of prostate cancer, UROLOGE A, 39(4), 2000, pp. 304-308
Authors:
Graefen, M
Hammerer, P
Haese, A
Huland, H
Citation: M. Graefen et al., Therapy options for hormon-refractory carcinoma of the prostate, UROLOGE A, 39(3), 2000, pp. 267-273
Authors:
Graefen, M
Hammerer, P
Noldus, J
Haese, A
Pichelmeier, U
Erbersdobler, A
Henke, H
Conrad, S
Fernandez, S
Huland, H
Citation: M. Graefen et al., Prognostic markers for prostate cancer, UROLOGE A, 39(1), 2000, pp. 14-21
Authors:
Hilz, H
Graefen, M
Noldus, J
Hammerer, P
Knabbe, C
Huland, E
Huland, H
Citation: H. Hilz et al., Advanced prostate cancer is associated with a decrease in serum luteinizing hormone, EUR UROL, 38(3), 2000, pp. 243-249
Authors:
Noldus, J
Graefen, M
Haese, A
Henke, RP
Hammerer, P
Huland, H
Citation: J. Noldus et al., Stage migration in clinically localized prostate cancer, EUR UROL, 38(1), 2000, pp. 74-78
Authors:
Wurmbach, JH
Hammerer, P
Sevinc, S
Huland, H
Ergun, S
Citation: Jh. Wurmbach et al., The expression of angiopoietins and their receptor Tie-2 in human prostatecarcinoma, ANTICANC R, 20(6D), 2000, pp. 5217-5220
Authors:
Hammerer, P
Graefen, M
Henke, RP
Haese, A
Palisaar, J
Huland, E
Huland, H
Citation: P. Hammerer et al., Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomy, ANTICANC R, 20(6D), 2000, pp. 5253-5255
Authors:
Erbersdobler, A
Graefen, M
Wullbrand, A
Hammerer, P
Henke, RP
Citation: A. Erbersdobler et al., Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: The impact of zonal location, Gleason grade, and tumour multifocality, PROSTATE C, 2(4), 1999, pp. 204-210
Authors:
Hilz, H
Noldus, J
Hammerer, P
Buck, F
Luck, M
Huland, H
Citation: H. Hilz et al., Molecular heterogeneity of free PSA in sera of patients with benign and malignant prostate tumors, EUR UROL, 36(4), 1999, pp. 286-292
Authors:
Graefen, M
Noldus, J
Pichlmeier, U
Haese, A
Hammerer, P
Fernandez, S
Conrad, S
Henke, RP
Huland, E
Huland, H
Citation: M. Graefen et al., Early prostate-specific antigen relapse after radical retropubic prostatectomy: Prediction on the basis of preoperative and postoperative tumor characteristics, EUR UROL, 36(1), 1999, pp. 21-30
Authors:
Haese, A
Huland, E
Graefen, N
Hammerer, P
Noldus, J
Huland, H
Citation: A. Haese et al., Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy, J UROL, 161(4), 1999, pp. 1206-1211
Risultati:
1-16
|